Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07528066) titled 'Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC' on April 7.

Study Type: Observational

Primary Sponsor: Shanghai Chest Hospital

Condition: Neoadjuvant Chemoimmunotherapy Robotic Pulmonary Resection Stage IIB-III NSCLC

Intervention: Procedure: Robotic-assisted surgery (RATS)

Recruitment Status: Recruiting

Date of First Enrollment: March 2, 2026

Target Sample Size: 200

Countries of Recruitment: China France Italy China France Italy

To know more, visit https://clinicaltrials.gov/study/NCT07528066

Disclaimer: Curated by HT Syndication....